143 related articles for article (PubMed ID: 15837836)
1. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation.
Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR
Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic activation initiates chamber dilatation in concentric hypertrophy.
Badenhorst D; Veliotes D; Maseko M; Tsotetsi OJ; Brooksbank R; Naidoo A; Woodiwiss AJ; Norton GR
Hypertension; 2003 Mar; 41(3):499-504. PubMed ID: 12623950
[TBL] [Abstract][Full Text] [Related]
3. Chronic beta-adrenoreceptor activation increases cardiac cavity size through chamber remodeling and not via modifications in myocardial material properties.
Gibbs M; Veliotes DG; Anamourlis C; Badenhorst D; Osadchii O; Norton GR; Woodiwiss AJ
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2762-7. PubMed ID: 15319203
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase inhibition promotes the transition from compensated hypertrophy to cardiac dilatation in rats.
Anamourlis C; Badenhorst D; Gibbs M; Correia R; Veliotes D; Osadchii O; Norton GR; Woodiwiss AJ
Pflugers Arch; 2006 Jan; 451(4):526-33. PubMed ID: 16211367
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation.
Osadchii O; Woodiwiss A; Alves N; Norton G
Life Sci; 2005 Dec; 78(4):366-75. PubMed ID: 16137710
[TBL] [Abstract][Full Text] [Related]
6. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction.
Woodiwiss AJ; Tsotetsi OJ; Sprott S; Lancaster EJ; Mela T; Chung ES; Meyer TE; Norton GR
Circulation; 2001 Jan; 103(1):155-60. PubMed ID: 11136701
[TBL] [Abstract][Full Text] [Related]
7. Improved myocardial beta-adrenergic responsiveness and signaling with exercise training in hypertension.
MacDonnell SM; Kubo H; Crabbe DL; Renna BF; Reger PO; Mohara J; Smithwick LA; Koch WJ; Houser SR; Libonati JR
Circulation; 2005 Jun; 111(25):3420-8. PubMed ID: 15967848
[TBL] [Abstract][Full Text] [Related]
8. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
Tsotetsi OJ; Woodiwiss AJ; Netjhardt M; Qubu D; Brooksbank R; Norton GR
Hypertension; 2001 Oct; 38(4):846-51. PubMed ID: 11641297
[TBL] [Abstract][Full Text] [Related]
10. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K
J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
[TBL] [Abstract][Full Text] [Related]
13. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
Lal A; Veinot JP; Leenen FH
Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats.
Kawasaki H; Cline WH; Su C
J Pharmacol Exp Ther; 1984 Oct; 231(1):23-32. PubMed ID: 6149303
[TBL] [Abstract][Full Text] [Related]
15. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.
Mottram PM; Haluska B; Leano R; Cowley D; Stowasser M; Marwick TH
Circulation; 2004 Aug; 110(5):558-65. PubMed ID: 15277317
[TBL] [Abstract][Full Text] [Related]
16. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
[TBL] [Abstract][Full Text] [Related]
17. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure.
Boluyt MO; Bing OH; Lakatta EG
Eur Heart J; 1995 Dec; 16 Suppl N():19-30. PubMed ID: 8682057
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic overload and apoptosis in heart failure: implications for therapy.
Colucci WS; Sawyer DB; Singh K; Communal C
J Card Fail; 2000 Jun; 6(2 Suppl 1):1-7. PubMed ID: 10908092
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.
Latini R; Masson S; Jeremic G; Luvarà G; Fiordaliso F; Calvillo L; Bernasconi R; Torri M; Rondelli I; Razzetti R; Bongrani S
J Cardiovasc Pharmacol; 1998 Apr; 31(4):601-8. PubMed ID: 9554811
[TBL] [Abstract][Full Text] [Related]
20. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
Brilla CG; Schencking M; Scheer C; Rupp H
Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
